Changeflow GovPing Government General AngioDynamics AccuVu Angiographic Catheter Reca...
Urgent Enforcement Amended Final

AngioDynamics AccuVu Angiographic Catheter Recall - Guidewire Passage Defect

Favicon for changeflow.com FDA Device Recalls (Class II)
Filed
Detected
Email

Summary

AngioDynamics initiated a Class II medical device recall for AccuVu Angiographic Catheters on March 3, 2026, due to a manufacturing defect that may prevent appropriately sized guidewires from passing through the catheter hub inner diameter. The recall affects 500 units (100 boxes) distributed to US facilities and 20 international markets. Urgent voluntary recall letters instructed consignees to immediately stop using, segregate, and return all affected product.

Published by FDA on accessdata.fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

AngioDynamics issued an urgent voluntary medical device recall for AccuVu Angiographic Catheters (Catalog No. 13709704, Lots A3025039 and A3225033) on March 3, 2026, after determining that affected devices contain a manufacturing defect (nonconforming component) that may prevent guidewires from passing through the catheter hub. The recall is classified as Class II and remains open with 500 units in commerce.

Healthcare facilities with any AccuVu angiographic catheters in stock should immediately check lot numbers against the recall, quarantine affected devices, and arrange return per the firm's instructions. The defect could affect intravascular procedure workflows where guidewire compatibility is critical. International consignees in 20 countries are similarly affected.

What to do next

  1. Stop using the devices subject to this recall and share the notification to all users of the devices within your facility immediately.
  2. Remove any affected items/lots from your inventory (whether in labs, Central Supply, Shipping and Receiving or ANY other location).
  3. Segregate this product in a secure location for return to AngioDynamics, Inc.

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Class 2 Device Recall Angiodynamics AccuVu

- Databases

| |

| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |

| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |

| New Search | ) |

| | Class 2 Device Recall Angiodynamics AccuVu | |

Date Initiated by Firm March 03, 2026
Date Posted April 17, 2026
Recall Status Open , Classified
Recall Number Z-1874-2026
Recall Event ID 98463
510(K)Number K112452 K161596
Product Classification Catheter, intravascular, diagnostic - Product Code DQO
Product AccuVu Angiographic Catheter, Omni Flush, Non-Braided, With 21 R/O Markers;

ACCU-VU OF 4F X 70CM 035 NB 6SH 21 R/O 1CM;
Catalog No.: 13709704;
Product/UPN No.: H787137097045 (Box), H787137097040 (Pouch);
Box Quantity: 5 pouches; |
| Code Information | ACCU-VU OF 4F X 70CM 035 NB 6SH 21 R/O 1CM;
Catalog No.: 13709704;
Product/UPN No.: H787137097045 (Box), H787137097040 (Pouch);
UDI-DI: 25051684006030(Box), 15051684006033(Pouch);
Lot No.: A3025039, A3225033; |
| FEI Number | 1319211 |
| Recalling Firm/
Manufacturer | Angiodynamics, Inc.
603 Queensbury Ave
Queensbury NY 12804-7619 |
| For Additional Information Contact | Kasey Newcomb
978-333-1108 |
| Manufacturer Reason
for Recall | The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner diameter (ID) of the catheter hub. |
| FDA Determined
Cause | Nonconforming Material/Component |
| Action | On March 3, 2026 URGENT VOLUNTARY MEDICAL DEVICE RECALL letters were sent to customers.
Actions to be taken:
IMMEDIATELY:
1. Stop using the devices subject to this recall and share the notification to all users of the deviceswithin your facility immediately.
2. Provide a copy of this recall notification to all sites or clinics to which you have distributed affectedproduct.
3. Remove any affected items/lots from your inventory (whether in labs, Central Supply, Shipping andReceiving or ANY other location).
4. Segregate this product in a secure location for return to AngioDynamics, Inc.
5. Package and Return the Recalled Product. |
| Quantity in Commerce | 500 units (100 boxes) |
| Distribution | Worldwide distribution - US Nationwide and the countries of Austria, Australia, Belgium, Canada, China, Chile, Curacao, Czech Republic, Germany, Ireland, Israel, Italy, Lebanon, Netherlands, New Zealand, Panama, Slovenia, South Africa, Spain, Sweden, Thailand. |
| Total Product Life Cycle | TPLC Device Report |

| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |

| 510(K) Database | 510(K)s with Product Code = DQO |

Get daily alerts for FDA Device Recalls (Class II)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
March 3rd, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall response Market withdrawal
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Product Safety

Get alerts for this source

We'll email you when FDA Device Recalls (Class II) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!